This article, entitled "Metastatic Breast Cancer Treatment Improvements," is presented by Genentech.
A lot has changed since Metastatic Breast Cancer Awareness Day was initiated five years ago to bring awareness to the unique concerns of people living with metastatic breast cancer, also known as Stage IV or advanced breast cancer. Most importantly, there have been new medicines developed that are helping people with HER2-posiitve metastatic breast cancer, an aggressive form of the disease, live longer.
There is good news this year for Breast Cancer Awareness Month as overall fewer people in the U.S. are dying from breast cancer and those living with the disease are living longer according to a national report on cancer incidence by the National Cancer Institute (NCI), American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC) and North American Association of Central Cancer Registries (NAACCR).
However, approximately 40,000 people die each year from metastatic breast cancer, so there is still much work to be done as we look ahead to the next five years. An estimated 144,000 Americans are currently living with metastatic breast cancer and tailored treatments are providing more options, but there is still no cure.
In the video below, 53-year-old Sharon Bozentka, mother of three who has been living with HER2-positive metastatic breast cancer for the last year along with oncologist, Dr. Marc Citron, will discuss the advances in treatments for metastatic breast cancer and what people need to know about this disease. Dr. Citron and Sharon will also explain the significance the awareness day has had on continued research into the disease and how women with metastatic breast cancer are coping with the disease.